| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10514308 | Journal of Clinical Epidemiology | 2012 | 5 Pages | 
Abstract
												Although often limited by lack of a control group and the need for complete case ascertainment to maintain data integrity, registries are a useful component of postmarketing pharmacovigilance systems for monitoring highly specialized medications associated with significant financial costs.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Public Health and Health Policy
												
											Authors
												Cameron D. Willis, John J. McNeil, Peter A. Cameron, Louise E. Phillips, 
											